Tech Company Financing Transactions
Versago Vascular Access Funding Round
Primo Medical Group and private investors invested in a $1.7 million Seed funding round for Versago Vascular Access. The round was announced on 2/25/2016.
Transaction Overview
Company Name
Announced On
2/25/2016
Transaction Type
Venture Equity
Amount
$1,650,000
Round
Seed
Investors
Primo Medical Group (Steve Tallarida)
Proceeds Purpose
The company's new funding will be used to further develop the Versago line of port technology, initiate regulatory review and conduct animal testing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
375 West St.
West Bridgewater, MA 02379
USA
West Bridgewater, MA 02379
USA
Phone
Email Address
Not Recorded
Overview
Versago is a true platform technology, spanning several fields with its unique design. Our patented technology displaces multiple traditional access applications in Apheresis and Chemotherapy, and opens several new ones such as Total Parenteral Nutrition, CAR-T and Hemodialysis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrea Patisteas
Chief Operating Officer
John Butziger
Browse more venture capital transactions:
Prev: 2/24/2016: Rani Therapeutics venture capital transaction
Next: 2/25/2016: buddybuild venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs